Medtronic PLC (NYSE:MDT)

The valuation ratios exhibit a general trend of contraction from the peak levels observed in mid-2021, followed by a multi-year period of relative stability and a subsequent decline in early 2026. Across all four metrics, there is a consistent pattern of significant devaluation during the first year of the period, suggesting a market correction or a shift in investor sentiment regarding the company's growth prospects.

Price to Earnings (P/E) Ratio

A substantial decline is observed from a peak of 46.71 in July 2021 to a low of 22.61 by July 2022. Following this correction, the ratio remained relatively stable, fluctuating between 23.38 and 30.94 through early 2026. The period concluded with a notable drop to 21.15 in April 2026, the lowest point in the recorded series.

Price to Operating Profit (P/OP) Ratio

The P/OP ratio closely mirrored the P/E trend, starting at 38.83 in July 2021 and descending to 17.99 by October 2022. Throughout 2023 and 2024, the ratio maintained a tight range, generally fluctuating between 18.58 and 22.10. Similar to other metrics, a final contraction is evident, with the ratio falling to 15.70 by April 2026.

Price to Sales (P/S) Ratio

A consistent downward trajectory is visible in the P/S ratio, which began at 5.74 in July 2021. The ratio experienced a steady decrease, reaching 3.42 by October 2022. While it remained largely range-bound between 3.18 and 3.89 from January 2023 to January 2026, it ended the period at its absolute minimum of 2.79 in April 2026.

Price to Book Value (P/BV) Ratio

The P/BV ratio declined from 3.52 in July 2021 to 2.03 by October 2022. Subsequent values showed modest volatility, peaking at 2.78 in October 2025 before returning to 2.05 by April 2026. This indicates that the market's valuation of the company relative to its equity has remained compressed compared to early 2021 levels.

In summary, the data indicates a systemic reduction in valuation multiples across earnings, operating profit, sales, and book value. The transition from high premiums in 2021 to lower, more stable multiples through 2025, ending with a sharp dip in early 2026, suggests a long-term trend of valuation compression.

The valuation metrics for the period between July 2021 and April 2026 exhibit a significant overall contraction in the price-to-earnings (P/E) multiple, transitioning from a high-growth valuation to a more conservative range. The data reveals a decoupled relationship between earnings performance and market valuation, where earnings remained relatively resilient while the share price experienced substantial volatility and a general downward trajectory.

Share Price Volatility

A pronounced downward trend is observed in the initial phase, with the share price declining from a peak of 134.73 in July 2021 to a low of 79.25 by October 2022. Although a partial recovery occurred, peaking at 105.35 in October 2025, the period concluded with a sharp decline to 79.34 in April 2026, effectively returning the stock to its 2022 valuation levels.

Earnings Per Share (EPS) Performance

Earnings demonstrated greater stability compared to the share price. EPS increased from 2.88 in July 2021 to a peak of 3.92 in July 2022. Following a mid-period dip to 2.72 in July 2023, a consistent recovery trend is evident, with EPS climbing back to 3.75 by April 2026. This indicates that the company's underlying profitability improved or stabilized even as market sentiment weakened.

Price-to-Earnings (P/E) Ratio Analysis

The P/E ratio underwent a dramatic compression, falling from 46.71 in July 2021 to 22.61 in July 2022. For the subsequent three years, the ratio fluctuated within a corridor of 23x to 31x, suggesting a period of valuation stabilization. However, the final data point in April 2026 shows the P/E ratio reaching its lowest level of 21.15, driven by the combination of a declining share price and rising earnings per share.

The convergence of increasing EPS and a decreasing share price toward the end of the observed period indicates a significant devaluation of the stock relative to its earnings power. The transition from a P/E of 46.71 to 21.15 reflects a fundamental shift in market pricing, moving from an aggressive valuation to one that is more aligned with value-oriented benchmarks.

The valuation trajectory indicates a period of significant contraction followed by a prolonged phase of stabilization and a final decline. While operational efficiency improved consistently over the observed timeframe, the market valuation failed to maintain its initial premiums, resulting in a compressed Price to Operating Profit (P/OP) ratio.

Share Price Movement

The share price exhibited substantial volatility, starting at a peak of 134.73 in July 2021 before undergoing a sharp decline to 79.25 by October 2022. A period of moderate recovery followed, with prices reaching a secondary peak of 105.35 in October 2025, before ultimately retreating to 79.34 by April 2026.

Operating Profit Performance

A consistent long-term upward trend is observed in the operating profit per share. This metric rose from 3.47 in July 2021 to 5.05 by April 2026. The steady increase in this figure suggests an improvement in operational efficiency and core profitability per share, regardless of the fluctuations experienced in the market price of the stock.

P/OP Ratio Dynamics

The P/OP ratio experienced a severe correction, dropping from 38.83 in July 2021 to 17.99 in October 2022. Following this correction, the ratio entered a stabilization phase, fluctuating within a narrow corridor between 18.58 and 22.10 from October 2022 through January 2026. The period concluded with a drop to 15.70 in April 2026, marking the lowest valuation multiple in the series and indicating a decreased market premium assigned to the company's operating profits.

The valuation metrics exhibit a sustained period of multiple compression, where the market's willingness to pay for each dollar of sales has steadily declined despite an improving fundamental revenue base. A significant divergence is observed between the consistent growth in sales per share and the volatile, generally downward trajectory of the share price.

Sales per Share Performance

A consistent upward trend is observed in sales per share, rising from 23.48 US$ in July 2021 to 28.41 US$ by April 2026. This indicates a steady growth in the top-line revenue generated per outstanding share over the entire period analyzed.

Share Price Volatility

The share price experienced a sharp contraction in the initial phase, falling from a peak of 134.73 US$ in July 2021 to 79.25 US$ by October 2022. Following this decline, the price entered a period of consolidation, fluctuating primarily between 80.00 US$ and 92.00 US$, with a temporary peak of 105.35 US$ in October 2025 before retreating to 79.34 US$ in April 2026.

Price-to-Sales (P/S) Ratio Trend

The P/S ratio reflects a significant overall decline, starting at 5.74 and ending at 2.79. The most aggressive compression occurred between July 2021 and October 2022, during which the ratio dropped to 3.42. A period of relative stability followed, with the ratio oscillating between 3.18 and 3.89 until the final decline to its period low of 2.79 in April 2026.

The synthesis of these trends indicates that the decline in the P/S ratio was driven primarily by the reduction in share price rather than a failure in revenue growth. Because sales per share increased while the P/S ratio decreased, it is evident that the market valuation shifted to a lower multiple of revenue, suggesting a fundamental re-rating of the stock's valuation profile over the observed timeframe.

An analysis of the Price to Book Value (P/BV) ratio reveals a period of significant valuation volatility driven primarily by fluctuations in market share price rather than changes in the underlying book value of the company.

Valuation Trend Analysis

The P/BV ratio experienced a substantial contraction during the initial phase of the observed period, falling from a peak of 3.52 in July 2021 to a low of 2.03 by October 2022. This decline represents a significant compression in the market premium attributed to the company's net assets. Following this trough, the ratio entered a period of relative stability between January 2023 and April 2024, generally oscillating between 2.05 and 2.26.

Recovery and Subsequent Correction

A moderate recovery in valuation occurred between July 2024 and October 2025, with the P/BV ratio climbing to a secondary peak of 2.78. This upward trajectory was closely correlated with an increase in the share price to 105.35. However, this trend reversed sharply in the final two quarters, with the ratio returning to 2.05 by April 2026, signaling a return to the valuation floors established in 2022 and 2023.

Book Value Stability

The Book Value per Share (BVPS) remained remarkably consistent throughout the entire timeframe, fluctuating within a narrow corridor between 37.34 and 39.63. Because the BVPS exhibited minimal variance, the volatility observed in the P/BV ratio is attributable almost exclusively to market sentiment and share price movements rather than shifts in the company's equity base or asset valuation.

Correlation Summary

The data demonstrates a direct and strong correlation between the share price and the P/BV ratio. The market's willingness to pay a premium over the book value shifted from a high of 3.52x to a baseline of approximately 2.05x, suggesting a fundamental repricing of the company's assets by investors over the five-year span.